Satoru Yonekura

26PUBLICATIONS
137CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Feb 06, 2025
Acetaminophen as a possible treatment option for pachydermoperiostosis carrying mutated SLCO2A1: Case series.

Tomoya Takegami, Mami I Mamiya, Satoru Yonekura

|Jul 03, 2023
Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy.

Satoru Yonekura, Yuichiro Endo, Hiroko Fujii

|Jun 08, 2023
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.

Marine Fidelle, Conrad Rauber, Carolina Alves Costa Silva

|Jul 27, 2022
FXYD3 Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment.

Satoru Yonekura, Kosuke Ueda

|Dec 21, 2021
Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.

Satoru Yonekura, Safae Terrisse, Carolina Alves Costa Silva

|Aug 27, 2021
EVI2B Is a New Prognostic Biomarker in Metastatic Melanoma with IFNgamma Associated Immune Infiltration.

Satoru Yonekura, Kosuke Ueda

Pageof 5

Frequent Collaborators

11 joint publications

Kenji Kabashima

9 joint publications

Saeko Nakajima

6 joint publications

Laurence Zitvogel

4 joint publications

Tomoya Takegami